MEDTR.E — Meditera Tibbi Malzeme Sanayi ve Ticaret AS Share Price
- TRY3.82bn
- TRY3.44bn
- TRY2.09bn
- 82
- 31
- 21
- 37
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 1.72 | ||
Price to Tang. Book | 1.72 | ||
Price to Free Cashflow | 8.28 | ||
Price to Sales | 1.83 | ||
EV to EBITDA | 12.41 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 9.73% | ||
Return on Equity | 3.37% | ||
Operating Margin | 10.92% |
Financial Summary
Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | TRYm | 359.32 | 375.93 | 1,595.74 | 2,096.77 | 2,094.35 | n/a | n/a | 55.27% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | +369.3 | +174.54 | -34.91 | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Meditera Tibbi Malzeme Sanayi ve Ticaret AS is a Turkey-based company, which is engaged in the design, productions, and wholesale trade of medical devices and equipment. The Company is specialized in the manufacture of anesthesia and intensive care circuits, the installation, operation and design of oncology drug preparation and delivery systems, production, sales and technical service of infusion pumps and sets, and the manufacture of biocidal products. Meditera Tibbi Malzeme manufactures surgical sutures and breathing circuits and accessories through its joint venture subsidiaries which established with Internacional Farmaceutica and S&Mohr. Additionally, The Company provides technical service, maintenance, and calibration services related to medical devices.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- February 14th, 1996
- Public Since
- July 2nd, 2021
- No. of Employees
- 765
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
Istanbul Stock Exchange
- Shares in Issue
- 117,683,797

- Address
- Tire OSB, IZMIR, 35900
- Web
- https://www.meditera.com.tr
- Phone
- +90 2325135110
- Auditors
- Arti Deger Uluslararasi Bagimsiz Denetim ve SMMM A.S.
Upcoming Events for MEDTR.E
Dividend For MEDTR.IS - 0.0840 TRY
Dividend For MEDTR.IS - 0.0840 TRY
Similar to MEDTR.E
Fonet Bilgi Teknolojileri AS
Istanbul Stock Exchange
Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS
Istanbul Stock Exchange
Seyitler Kimya Sanayi AS
Istanbul Stock Exchange
FAQ
As of Today at 21:59 UTC, shares in Meditera Tibbi Malzeme Sanayi ve Ticaret AS are trading at TRY32.50. This share price information is delayed by 15 minutes.
Shares in Meditera Tibbi Malzeme Sanayi ve Ticaret AS last closed at TRY32.50 and the price had moved by +0.83% over the past 365 days. In terms of relative price strength the Meditera Tibbi Malzeme Sanayi ve Ticaret AS share price has underperformed the FTSE Global All Cap Index by -1.7% over the past year.
There is no consensus recommendation for this security.
Find out moreThe Meditera Tibbi Malzeme Sanayi ve Ticaret AS dividend yield is 0.78% based on the trailing twelve month period.
Last year, Meditera Tibbi Malzeme Sanayi ve Ticaret AS paid a total dividend of TRY0.25, and it currently has a trailing dividend yield of 0.78%.Looking ahead, shares in Meditera Tibbi Malzeme Sanayi ve Ticaret AS are due to go ex-dividend on 2025-07-28 and the next dividend pay date is 2025-07-30.
Meditera Tibbi Malzeme Sanayi ve Ticaret AS are due to go ex-dividend on 2025-07-28 and the next dividend pay date is 2025-07-30. The historic dividend yield on Meditera Tibbi Malzeme Sanayi ve Ticaret AS shares is currently 0.78%.
To buy shares in Meditera Tibbi Malzeme Sanayi ve Ticaret AS you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of TRY32.50, shares in Meditera Tibbi Malzeme Sanayi ve Ticaret AS had a market capitalisation of TRY3.82bn.
Here are the trading details for Meditera Tibbi Malzeme Sanayi ve Ticaret AS:
- Country of listing: Turkey
- Exchange: IST
- Ticker Symbol: MEDTR.E
Based on an overall assessment of its quality, value and momentum Meditera Tibbi Malzeme Sanayi ve Ticaret AS is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Meditera Tibbi Malzeme Sanayi ve Ticaret AS. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -31.58%.
As of the last closing price of TRY32.50, shares in Meditera Tibbi Malzeme Sanayi ve Ticaret AS were trading -25.56% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Meditera Tibbi Malzeme Sanayi ve Ticaret AS PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at TRY32.50.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Meditera Tibbi Malzeme Sanayi ve Ticaret AS' directors